concept

ASTROCYTES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ASTROCYTES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5584Connections
11Hypotheses
3Analyses
50Outgoing
50Incoming
15Experiments
4Debates

Summary

Astrocytes are the most abundant glial cells in the CNS, performing critical roles in blood-brain barrier maintenance, neurotransmitter recycling (glutamate uptake via GLT-1), metabolic support (astrocyte-neuron lactate shuttle), ion homeostasis (K+ buffering), and synapse formation/pruning. Astrocytes form the glymphatic system, a brain-wide waste clearance network that removes amyloid-beta and tau during sleep via AQP4 water channels. In neurodegeneration, astrocytes become reactive: A1 astrocytes (induced by microglia via TNF-alpha, IL-1alpha, C1q) are neurotoxic, while A2 astrocytes are neuroprotective. Reactive astrogliosis is a hallmark of AD, PD, ALS, and MS. Therapeutic targeting of astrocyte reactivity, glutamate transport, and glymphatic function are active research areas.

View on Wiki →

AI portrait of ASTROCYTES

AI-generated illustration

Regenerate portrait ↻
💡 Concept Info
NameASTROCYTES
Key Genes/Proteins67LR, 6-OHDA, ABCA1, ABCG1, ABCG4, ACETYL-COA
Related DiseasesACETYLCHOLINE, Addiction

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Astrocytes

cell · 3974 words

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        ASTROCYTES["ASTROCYTES"] -->|"regulates"| Als["Als"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| AKT["AKT"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| Multiple_Sclerosis["Multiple Sclerosis"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| Autoimmune["Autoimmune"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| Dementia["Dementia"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| Alzheimer["Alzheimer"]
        ASTROCYTES["ASTROCYTES"] -->|"regulates"| Inflammation["Inflammation"]
        ASTROCYTES["ASTROCYTES"] -->|"regulates"| Neuroinflammation["Neuroinflammation"]
        ASTROCYTES["ASTROCYTES"] -->|"activates"| Als_1["Als"]
        TNF["TNF"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
        CYTOKINES["CYTOKINES"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
        COMPLEMENT["COMPLEMENT"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
    end
    subgraph Therapeutic["Therapeutic"]
        GFAP["GFAP"] -->|"expressed in"| ASTROCYTES["ASTROCYTES"]
    end
    style ASTROCYTES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Multiple_Sclerosis fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autoimmune fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Dementia fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TNF fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GFAP fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style COMPLEMENT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURODEGENERATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (3156)

TargetRelationTypeStr
Agingactivatesdisease1.00
Inflammationactivatesdisease1.00
Neurodegenerationregulatesdisease1.00
Strokeactivatesdisease1.00
Apoptosisactivatespathway1.00

Incoming (2428)

SourceRelationTypeStr
INFLAMMATIONactivatesgene1.00
AMYLOIDactivatesgene1.00
ALSassociated_withgene1.00
IL-6activatesgene1.00
OXIDATIVE STRESSactivatesgene1.00

Targeting Hypotheses (11)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
AMPK hypersensitivity in astrocytes creates enhanced mitocho 0.813 neurodegeneration Mitochondrial transfer between astrocyte
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC 0.760 neuroscience APOE4-driven lipid metabolism dysregulat
Circadian Rhythm Entrainment of Reactive Astrocytes 0.722 neurodegeneration Astrocyte reactivity subtypes in neurode
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A 0.710 neuroscience APOE4-driven lipid metabolism dysregulat
GFAP-Bearing Circulating Extracellular Vesicles Originating 0.640 - What blood-brain barrier permeability ch
H1: Senolytic Clearance of Senescent APOE4 Astrocytes 0.610 neurodegeneration Do APOE4-driven senescent astrocytes cau
H5: Complement Dysregulation Drives Synapse Loss via Senesce 0.580 neurodegeneration Do APOE4-driven senescent astrocytes cau
AQP4 Missorting in Reactive Astrocytes Drives Glymphatic Fai 0.580 neurodegeneration What are the specific molecular mechanis
APOE4 astrocytes fail to supply sufficient cholesterol to pa 0.500 neuroscience APOE4-driven lipid metabolism dysregulat
Reactive astrocytes and cholinesterase-rich low-acetylcholin 0.440 neurodegeneration What determines the temporal sequence of
XOR+ stress-responsive astrocytes represent a novel AD-assoc 0.000 Alzheimer's disease scRNA-seq Processing and Cell Type Annot

Mentioning Analyses (3)

Scientific analyses that reference this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

neurodegeneration | 2026-04-10 | 0 hypotheses

Which cell types show the most significant expression changes for neurodegenerat

neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.682

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847

Experiments (15)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Circadian gene expression effects of SD vs ketamine exploratory depression 0.950 0.00 C57BL/6J mice proposed N/A
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD exploratory Parkinson's disease 0.900 0.00 iPSC-derived dopaminergic neur proposed N/A
CLOCK/BMAL1 regulation of ICC autophagy in GERD model exploratory gastroesophageal reflux diseas 0.900 0.00 primary esophageal interstitia proposed N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an falsification Neurodegeneration 0.400 0.50 cell_line completed $100,000
Metabolic Pathway-Targeted Therapy in ALS clinical ALS 0.400 0.50 human proposed $6,550,000
Animal Model Comparison for Neurodegenerative Disease Therapeutics clinical Alzheimer's Disease 0.400 0.50 human proposed $7,100,000
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso validation Parkinson's Disease 0.400 0.50 human proposed $3,000,000
Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec validation Neurodegeneration 0.400 0.50 cell_line proposed $160,000
GLP-1 Agonist Neuroprotection Mechanism in PD clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Brainstem Circuit Modulation for PSP clinical ALS 0.400 0.50 human proposed $5,460,000
Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury. [PMID:40269168] Ruan W, Li T, Bang IH, Lee J, Deng W, Ma Nature 2025 1
Obstructive sleep apnea syndrome, orexin, and sleep-wake cycle: The link with th [PMID:39864923] Fernandes M, Liguori C Handb Clin Neurol 2025 1
Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases. [PMID:39728504] Hussain Y, Dar MI, Pan X Metabolites 2024 1
Circadian rhythm regulates the function of immune cells and participates in the [PMID:38678017] Zeng Y, Guo Z, Wu M, Chen F, Chen L Cell Death Discov 2024 1
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] Han QQ, Shen SY, Liang LF, Chen XR, Yu J Brain Behav Immun 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Circadian Clock Regulation on Lipid Metabolism and Metabolic Diseases. [PMID:32705594] Pan X, Mota S, Zhang B Adv Exp Med Biol 2020 1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] Wang Y, An H, Liu T, Qin C, Sesaki H, Gu Cell Rep 2019 1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] Song X, Zhu S, Chen P, Hou W, Wen Q, Liu Curr Biol 2018 1
Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuro [PMID:26121488] Hang L, Thundyil J, Lim KL Ann N Y Acad Sci 2015 1
AMPKα1 Deficiency in Macrophages Impairs Tendon Regeneration and Tendon Stem Cel [PMID:41694579] Zhu L, Wang Y, Shi X, Yu M, Cai X, Chen International journal of biolo 2026 0
Single-cell transcriptome analysis reveals a cellular immune response in common [PMID:41692207] Shi X, Ji G, Liu D, Zhao T, Tian S, Li S International journal of biolo 2026 0
Farrerol ameliorates hepatic insulin resistance via AMPKα1/mTOR/SREBP-1 pathway: [PMID:41702183] Li Y, Feng X, Zheng L Tissue & cell 2026 0
BMAL1 attenuates myocardial infarction-induced fibrosis via suppressing p-SMAD3/ [PMID:41909150] Zhang D, Wang H, Gu Z, Zhang L, Hu Z, Wa Biochemistry and biophysics re 2026 0
Multifunctional hydrogel delivery of mesenchymal stem cell secretome suppresses [PMID:41092646] Lin L, Liang X, Xu Z, Li Y, Guo Z et al. Biomaterials 2026 0
The Liver Clock Tunes Transcriptional Rhythms in Skeletal Muscle to Regulate Mit [PMID:41486525] Sica V, Sato T, Tsialtas I, Hernandez S, J Biol Rhythms 2026 0
Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-pr [PMID:41578008] Tsameret S, Froy O, Matz Y, Landau Z, Tw Diabetologia 2026 0
Bmal1 Regulates Vascular Calcification via Noncanonical Circadian Pathway-Brief [PMID:41608773] He M, Sun Y, Tang C, Huang F, Zhu Z et a Arterioscler Thromb Vasc Biol 2026 0
Liver-specific knockout of CD73 exacerbated alcohol-associated steatohepatitis b [PMID:41833677] Wu X, Zhang Q, Wang QQ, Liu ZN, Ni YY et Int J Biol Macromol 2026 0
Integrative SMR prioritizes oxidative stress-related regulatory genes for Alzhei [PMID:41844011] Wu L, Dong YT, Mu X, Luo X, Chen ZJ J Prev Alzheimers Dis 2026 0

Debates (4)

Multi-agent debates referencing this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.66 · 2026-04-21

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.64 · 2026-04-21

The debate mentioned gene expression profiling but did not specify which neural

closed · Rounds: 4 · Score: 0.93 · 2026-04-03

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

closed · Rounds: 4 · Score: 0.90 · 2026-04-03

Related Research

Hypotheses and analyses mentioning ASTROCYTES in their description or question text

H1: Senolytic Clearance of Senescent APOE4 Astrocytes

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview H1: Senolytic Clearance of Senescent APOE4 Astrocytes starts from the claim that modulating CDKN

H5: Complement Dysregulation Drives Synapse Loss via Senescent APOE4 Astrocytes

Score: 0.580 · neurodegeneration · 2026-04-22

## Mechanistic Overview H5: Complement Dysregulation Drives Synapse Loss via Senescent APOE4 Astrocytes starts from the

AQP4 Missorting in Reactive Astrocytes Drives Glymphatic Failure in Chronic Neur

Score: 0.580 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of brain hom

APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneuro

Score: 0.500 · neuroscience · 2026-04-22

## Mechanistic Overview APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneurons, causing pres

Reactive astrocytes and cholinesterase-rich low-acetylcholine niches amplify tau

Score: 0.440 · neurodegeneration · 2026-04-25

Reactive astrocytes may degrade acetylcholine and destabilize cortical network states, secondarily creating conditions p

XOR+ stress-responsive astrocytes represent a novel AD-associated cell state lin

Score: 0.000 · Alzheimer's disease · 2026-04-26

Single-cell analysis of AD brains will reveal a distinct astrocyte subpopulation characterized by upregulated xanthine o